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Abstract
Multiple sclerosis (MS) is an autoimmune disease with high prevalence among populations
of northern European ancestry. Past studies have shown that exposure to ultraviolet radiation could explain the difference in MS prevalence across the globe. In this study, we investigate whether the difference in MS prevalence could be explained by European genetic
risk factors. We characterized the ancestry of MS-associated alleles using RFMix, a conditional random field parameterized by random forests, to estimate their local ancestry in the
largest assembled admixed population to date, with 3,692 African Americans, 4,915 Asian
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Americans, and 3,777 Hispanics. The majority of MS-associated human leukocyte antigen
(HLA) alleles, including the prominent HLA-DRB1*15:01 risk allele, exhibited cosmopolitan
ancestry. Ancestry-specific MS-associated HLA alleles were also identified. Analysis of the
HLA-DRB1*15:01 risk allele in African Americans revealed that alleles on the European
haplotype conferred three times the disease risk compared to those on the African haplotype. Furthermore, we found evidence that the European and African HLA-DRB1*15:01
alleles exhibit single nucleotide polymorphism (SNP) differences in regions encoding the
HLA-DRB1 antigen-binding heterodimer. Additional evidence for increased risk of MS
conferred by the European haplotype were found for HLA-B*07:02 and HLA-A*03:01 in
African Americans. Most of the 200 non-HLA MS SNPs previously established in European
populations were not significantly associated with MS in admixed populations, nor were they
ancestrally more European in cases compared to controls. Lastly, a genome-wide search of
association between European ancestry and MS revealed a region of interest close to the
ZNF596 gene on chromosome 8 in Hispanics; cases had a significantly higher proportion
of European ancestry compared to controls. In conclusion, our study established that the
genetic ancestry of MS-associated alleles is complex and implicated that difference in MS
prevalence could be explained by the ancestry of MS-associated alleles.

Author summary
Multiple sclerosis (MS) is an autoimmune disease that is mostly found in populations
with northern European ancestry. Our study investigates whether there is evidence that
the difference in MS prevalence around the globe could be explained by European MS
genetic risk factors in African Americans, Hispanics, or Asian Americans. Our work first
established that most alleles associated with MS are not necessarily European, but are in
fact, cosmopolitan. However, we also observed in African Americans that European HLADRB1� 15:01 conferred three times the odds of MS compared to the African allele. The
allele HLA-DRB1� 15:01 has been shown to be a major genetic risk factor in Europeans
and other admixed populations. In addition, we observed genetic variations between
European and African HLA-DRB1� 15:01 alleles that, based on location, could influence
the function of antigen-binding proteins involved in MS. Consequently, it is plausible that
ancestry could explain the risk or protective effects of other MS-associated alleles. Additionally, our study found on chromosome 8 in Hispanics a region where MS cases have
more European ancestry than controls, implicating there may be new MS risk alleles to be
discovered in Hispanics. In conclusion, our study found evidence that the difference in
MS prevalence could be explained by European ancestry and established that the ancestry
of MS genetic risk factors is complex.

Introduction
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that results in
demyelination and tissue loss. Association studies in White, non-Hispanic populations have
discovered human leukocyte antigen (HLA) alleles conferring strong risk and protective effects
and 200 non-HLA genetic risk variants conferring modest risk of MS[1,2]. Evidence that HLA
class II alleles interact to confer greater risk of MS have been found[3]. Together, identified
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MS genetic risk factors are estimated to explain up to 30% of total heritability, of which most is
accounted for by HLA alleles[2,4].
The prevalence of MS varies across the globe but is highest in White, non-Hispanic populations. There is evidence that African Americans are at higher risk for developing the disease,
and along with Hispanics, may have a more severe disease course. Incidentally, countries with
majority White, non-Hispanic individuals and experience highest MS prevalence are located
at higher latitudes. Past studies have not only established the association between ultraviolet
radiation and MS prevalence, but have also found evidence supporting the causal role of low
vitamin D on MS risk. In this study, we investigate another hypothesis—that the difference in
MS prevalence across the globe can be explained by European ancestry. If European ancestry
can explain this difference, then MS-associated alleles in admixed individuals can either be
European or confer increased risk on a European haplotype compared to a non-European
haplotype.
We investigate this by analyzing the genetic ancestry of MS-associated alleles in a large
combined cohort totaling 1,471 MS cases and 10,913 controls including African American,
Asian American, and Hispanic individuals. Previous studies have been able to replicate the
association of the HLA risk allele HLA-DRB1� 15:01 in nearly all populations[5]. Additional
HLA alleles have been found to be associated with MS in non-European populations, such as
HLA-DRB1� 15:03 in African Americans and HLA-DRB1� 04:05 in the Japanese population[6].
Limited replication has been achieved for non-HLA genetic risk variants in other populations
[7–9]. We found that most MS-associated alleles are cosmopolitan, but there is evidence that
European risk alleles may confer more risk than non-European risk alleles, most notably for
the major risk allele HLA-DRB1� 15:01. Thus, there is evidence that the difference in MS prevalence could be explained by European ancestry. We also tested for the association of European
ancestry with MS across the genome in African Americans, Asian Americans and Hispanics,
and found a signal of association on chromosome 8 in Hispanics.

Results
Analysis of population structure
We performed multidimensional scaling (MDS) analysis on genotype data from 21,647 subjects to generate components used to control for population stratification in later analyses (Fig
1A, S19 Table). This analysis was done separately for African American samples which were
genotyped using the Illumina Immunochip (Fig 1B, S19 Table). The first three components
were sufficient to differentiate global ancestries and broadly categorize samples as African
Americans, Asian Americans, or Hispanics. Component 2 was correlated with African ancestry in African Americans (R = 1.00, p < 0.01), component 1 was correlated with Native American ancestry in Hispanics (R = -0.95, p < 0.01), and component 1 was correlated with East
Asian ancestry in Asian Americans (R = 0.99, p < 0.01).
We used fastSTRUCTURE to estimate global admixture proportions for individuals from
each admixed population. After eliminating White, non-Hispanic individuals and Hispanics
with less than 5% Native American ancestry, a total of 3,692 African Americans, 4,915 Asian
Americans, and 3,777 Hispanics comprised the final dataset (Table 1). African Americans
were estimated to be 76.1% African and 23.9% European on average, Asian Americans were
estimated to be 92.2% East Asian and 7.8% European on average, and Hispanics were estimated to be 68.4% European, 28.8% Native American, and 2.8% African on average, in line
with published estimates[10].
The average global admixture for MS cases and controls is shown in Fig 2 (S20 Table). We
observed significant differences in global admixture proportions between cases and controls
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Fig 1. Multidimensional scaling analysis of study subjects with HGDP reference samples. (A) Study subjects from
Northern California Kaiser Permanente, Southern California Kaiser Permanente, U.S. Pediatric MS Network, Genetic
Epidemiology Research on Aging datasets, and (B) IMSGC Immunochip.
https://doi.org/10.1371/journal.pgen.1007808.g001

across all populations. African American cases had 5.0% increased African ancestry compared
to controls (p < 0.01); Hispanic cases had 5.4% increased Native American ancestry (p = 0.02)
and 11.3% decreased European ancestry (p < 0.01) compared to controls. Asian American
cases had 23.0% increased European ancestry compared to controls (p < 0.01).
Table 1. Number of cases and controls by admixed population.
Population

Case (n)

Control (n)

1,081

2,611

Hispanics

326

3,451

Asian Americans

64

4,851

African Americans

Number of MS cases and controls for African American, Hispanic, and Asian American datasets, after removing
related individuals (^
p > 0:25), White, non-Hispanic subjects, and Hispanics with less than 5% Native American
ancestry. n = number of individuals.
https://doi.org/10.1371/journal.pgen.1007808.t001
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Fig 2. Global admixture proportions of study subjects. Global admixture proportion estimates by fastSTRUCTURE with HGDP
reference samples. Proportions are shown by case/control status and with cases and controls combined for (A) African Americans,
(B) Hispanics, and (C) Asian Americans. The x-axis label ‘All’ denotes admixture proportions for cases and controls combined. See
Table 1 for the sample numbers corresponding to each admixed population.
https://doi.org/10.1371/journal.pgen.1007808.g002

Ancestry association at the MHC
In previous studies, up to eleven regions within the major histocompatibility complex (MHC)
have been identified to exhibit statistically significant independent effects of association with
MS in White, non-Hispanic populations: six HLA-DRB1, one HLA-DPB1, one HLA-A, two
HLA-B alleles, and one signal in a region spanning from MICB to LST1[11]. We tested each of
these regions, in addition to regions spanned by DQB1 and HLA-C and the broader regions
class I, II, and III, for evidence of increased European ancestry in MS cases compared to
controls. Results are summarized in Tables 2–4 and shown in Fig 3 (S21 Table). In African
Table 2. European ancestry association with MS at regions of the MHC in African Americans.
z�l; d ðkÞ

z�l;c ðkÞ

q� c ðkÞ

z score

P value

HLA A

9.12E-3

-1.32E-2

2.04

2.06E-2

Class I

8.78E-3

-1.19E-2

1.91

2.83E-2

MICB-LST1

8.66E-3

-1.09E-2

1.78

3.79E-2

HLA B

8.19E-3

-1.11E-2

1.75

4.05E-2

HLA C

9.12E-3

-9.96E-3

1.72

4.24E-2

Class III

8.84E-3

-8.59E-3

1.59

5.57E-2

DQB1

1.00E-3

-7.28E-3

1.57

5.80E-2

DRB1

1.00E-3

-7.28E-3

1.57

5.80E-2

Class II

9.70E-3

-6.27E-3

1.47

7.10E-2

DPB1

9.58E-3

-2.87E-3

1.13

1.30E-1

MHC Region

q� d ðkÞ

Tests of European ancestry association with MS using test statistic for admixture mapping, sorted by P value. The
q�d ðkÞ represents difference in average local and global European ancestry (k) proportions for cases

column z�l; d ðkÞ

d. The column �
z l; c ðkÞ

q�c ðkÞ is defined similarly as �
z l; d ðkÞ

q�d ðkÞ for controls c. The z score is the admixture

mapping test statistic calculated as described in Materials and Methods. Adj P value is Bonferroni-adjusted p value.
https://doi.org/10.1371/journal.pgen.1007808.t002
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Table 3. European ancestry association with MS at regions of the MHC in Hispanics.
z�l; d ðkÞ

q� d ðkÞ

z�l;c ðkÞ

q� c ðkÞ

z score

P value

Class I

-5.18E-2

-8.48E-2

1.57

5.76E-2

HLA A

-5.06E-2

-8.39E-2

1.55

6.11E-2

HLA C

-5.83E-2

-9.04E-2

1.51

6.51E-2

HLA B

-5.98E-2

-8.89E-2

1.38

8.43E-2

Class III

-5.09E-2

-7.55E-2

1.22

1.12E-1

MICB-LST1

-6.29E-2

-8.60E-2

1.11

1.34E-1

DQB1

-4.60E-2

-6.72E-2

1.02

1.54E-1

DRB1

-4.60E-2

-6.72E-2

1.02

1.54E-1

Class II

-4.00E-2

-5.32E-2

0.66

2.54E-1

DPB1

-2.76E-2

-2.91E-2

0.07

4.71E-1

MHC Region

Tests of European ancestry association with MS using test statistic for admixture mapping, sorted by P value. The column z�l; d ðkÞ
average local and global European (k) ancestry proportions for cases d. The quantity z�l; c ðkÞ

q�d ðkÞ represents difference in

q�c ðkÞ is defined similarly for controls c. The z score is the admixture

mapping test statistic calculated as described in Materials and Methods.
https://doi.org/10.1371/journal.pgen.1007808.t003

Americans, cases exhibited increased European ancestry at the MHC region compared to controls, after accounting for global admixture proportion differences, with genes in the class I
region and the MICB-LST1 region reaching statistical significance (p < 0.05). In Hispanics,
the direction of association was the same as in African Americans, but none of the regions
reached statistical significance. In Asian Americans, the cases had decreased European ancestry at the MHC region compared to controls, with the regions HLA-DQB1 and HLA-DRB1
demonstrating evidence for statistical significance (p < 0.05).

Ancestry of MS-associated HLA alleles
We investigated the ancestry of MS-associated HLA alleles to determine whether ancestry
associations observed at the regions within the MHC could be explained. We first identified
HLA alleles associated with MS in each admixed group using additive multivariate logistic
Table 4. European ancestry association with MS at regions of the MHC in Asian Americans.
MHC Region

z�l; d ðkÞ

q� d ðkÞ

z�l;c ðkÞ

q� c ðkÞ

z score

P value

DQB1

-1.60E-2

5.98E-2

-1.67

4.80E-2

DRB1

-1.60E-2

5.98E-2

-1.67

4.80E-2

HLA A

-3.94E-2

3.21E-2

-1.56

5.94E-2

Class II

-1.67E-2

5.35E-2

-1.52

6.39E-2

Class III

-7.52E-3

5.83E-2

-1.48

7.00E-2

DPB1

-2.38E-2

4.32E-2

-1.43

7.69E-2

MICB-LST1

-8.18E-3

5.37E-2

-1.36

8.62E-2

Class I

-1.90E-2

4.07E-2

-1.33

9.24E-2

HLA B

-3.69E-4

5.28E-2

-1.14

1.27E-1

HLA C

-3.69E-4

5.27E-2

-1.14

1.27E-1

Tests of European ancestry association with MS using test statistic for admixture mapping, sorted by P value. The
q�d ðkÞ represents difference in average local and global European (k) ancestry proportions for cases

column z�l; d ðkÞ

d. The quantity �
z l; c ðkÞ

q�c ðkÞ is defined similarly for controls c. The z score is the admixture mapping test statistic

calculated as described in Materials and Methods.
https://doi.org/10.1371/journal.pgen.1007808.t004
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Fig 3. Deviation of local from global European ancestry. The difference between local and global ancestry at the major
histocompatibility complex (MHC) region, plotted for cases and controls. The red vertical bars denote borders of class I, II, and III of
the MHC. Local and global ancestries are estimated with RFMix. For both (A) African Americans and (B) Hispanics, cases tended to
have higher European ancestry than controls at the MHC. For (C) Asian Americans, cases tended to have lower European ancestry
than controls at the MHC.
https://doi.org/10.1371/journal.pgen.1007808.g003
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Fig 4. Comparison of MS-associated HLA alleles across populations. P-value heat map for HLA alleles that reached Bonferroni
significance in either Asian Americans, African Americans, Hispanics, or White, non-Hispanic individuals. P-values of HLA alleles
associated with MS in White, non-Hispanic individuals were taken from previous work[11]. The HLA allele HLA-DRB1� 15:01 was
most consistently associated with MS across all four populations, followed by HLA-DRB1� 03:01. Gray (NA) denotes an HLA allele
that is missing due to not being present in the population or failed to pass HLA imputation QC.
https://doi.org/10.1371/journal.pgen.1007808.g004

regression, adjusting for the first three MDS components. We observed 14 alleles in African
Americans, 15 alleles in Hispanics, and 4 alleles in Asian Americans that reached nominal significance of association (p < 0.05). HLA-DRB1� 15:01, the strongest genetic association with
MS observed in White, non-Hispanic individuals, to date, was a top signal across all three
admixed populations, consistent with previous findings[5]. As expected, the African allele
HLA-DRB1� 15:03 was significantly associated with MS in African Americans[12]. In African
Americans, we further replicated the association of HLA risk alleles previously established in
the White, non-Hispanic population: HLA-DRB1� 03:01, HLA-A� 02:01, HLA-DRB1� 14:01, and
HLA-B� 38:01 at nominal level significance (p < 0.05)[11]. In both Hispanics and Asian Americans, HLA-DRB1� 15:01 is the only established HLA risk alleles in White, non-Hispanics that
was replicated. Fig 4 (S22 Table) compares the p-values of significant MS-associated HLA
alleles across different populations. With our sample sizes, we estimate close to 100% power
of detection for African Americans and Hispanics and 80% power for Asian Americans.
Assuming the MS HLA alleles found in the European population are also associated with MS
in admixed populations, then 6, 7, and 4 HLA alleles are expected to be detected in African
Americans, Hispanics, and Asian Americans respectively, post quality control.
Next, we estimated the admixture proportions of all the nominally-associated alleles using
local ancestry estimates from RFMix. Analysis of HLA alleles and corresponding admixture
proportions are shown in Tables 5–7, and Fig 5 (S23 Table). Ancestry estimates for HLA
alleles previously established to be ancestry-specific were in strong agreement: 98.4% East
Asian for the East Asian allele HLA-DRB1� 04:05 in Asian Americans (n = 692 alleles), 96.2%
European for the European allele HLA-DRB1� 01:01 in Hispanics (n = 395 alleles), 96.4%
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Table 5. Ancestry of HLA alleles associated with MS in African Americans.
N

OR

P value

Adj P value

EUR

AFR

HLA-DRB1� 15:01

Allele

512

2.00 (1.58–2.55)

1.26E-8

8.83E-7

0.64

0.36

HLA-DRB1� 03:01

658

1.45 (1.22–1.72)

2.61E-5

1.83E-3

0.34

0.66

HLA-B� 07:02

598

1.48 (1.23–1.78)

3.61E-5

2.53E-3

0.53

0.47
1.00

�

HLA-DRB1 15:03

881

1.37 (1.17–1.59)

8.11E-5

5.68E-3

0.00

HLA-DRB1� 14:01

106

0.39 (0.22–0.70)

1.37E-3

9.58E-2

0.49

0.51

HLA-A� 03:01

694

1.3 (1.10–1.54)

1.97E-3

1.38E-1

0.38

0.62

HLA-A� 02:01

914

0.8 (0.68–0.94)

7.88E-3

5.51E-1

0.48

0.52

HLA-C� 08:02

198

1.44 (1.07–1.94)

1.47E-2

1.00E+0

0.21

0.79

HLA-B� 55:01

45

0.24 (0.07–0.78)

1.74E-2

1.00E+0

0.98

0.02

HLA-DRB1� 13:01

476

0.76 (0.60–0.96)

2.09E-2

1.00E+0

0.20

0.80

HLA-C� 04:01

1704

0.87 (0.76–0.98)

2.35E-2

1.00E+0

0.13

0.87

HLA-C 07:02

708

1.22 (1.02–1.45)

2.55E-2

1.00E+0

0.48

0.52

HLA-B� 38:01

43

0.28 (0.09–0.94)

3.87E-2

1.00E+0

0.91

0.09

HLA-C� 03:02

95

0.57 (0.33–0.98)

4.30E-2

1.00E+0

0.00

1.00

�

HLA alleles that were nominally associated with MS (p < 0.05) and their ancestry proportions estimated from RFMix. Odds ratio (OR) of association for case-control
comparison are also shown along with their 95% confidence interval. All tested HLA alleles passed imputation quality score (R2 > 0.80) and have allele frequencies
greater than 0.005. N = number of alleles; EUR = European; AFR = African; Adj P value = Bonferroni adjusted p-value.
https://doi.org/10.1371/journal.pgen.1007808.t005

Native American for Native American allele HLA-DRB1� 14:02 in Hispanics (n = 454 alleles),
and 99.5% African for African allele HLA-DRB1� 15:03 in African Americans(n = 881 alleles)
[13]. Most MS-associated HLA alleles are cosmopolitan across the admixed populations. The
MS risk allele HLA-DRB1� 15:01, which is more common in Europeans, was estimated to be
63.7% European in African Americans (n = 512 alleles) and 96.4% European in Hispanics
Table 6. Ancestry of HLA alleles associated with MS in Hispanics.
N

OR

P value

Adj P value

EUR

AMR

AFR

HLA-DRB1� 15:01

Allele

534

2.45 (1.88–3.19)

2.59E-11

2.00E-9

0.96

0.02

0.02

HLA-DRB1� 16:02

180

1.92 (1.23–2.99)

4.11E-3

3.17E-1

0.01

0.97

0.02

HLA-DRB1� 13:01

314

0.47 (0.27–0.84)

1.13E-2

8.66E-1

0.81

0.03

0.17

HLA-C� 04:01

1601

0.76 (0.61–0.95)

1.52E-2

1.00E+0

0.22

0.68

0.1

HLA-DRB1� 01:01

395

0.54 (0.33–0.89)

1.65E-2

1.00E+0

0.96

0.01

0.03

HLA-B� 08:01

318

1.54 (1.08–2.21)

1.71E-2

1.00E+0

0.93

0.02

0.05

HLA-B 40:02

545

1.39 (1.05–1.84)

2.22E-2

1.00E+0

0.09

0.91

0.00

HLA-DRB1� 14:02

454

0.60 (0.39–0.94)

2.49E-2

1.00E+0

0.03

0.96

0.01

HLA-C� 08:02

327

1.52 (1.05–2.20)

2.53E-2

1.00E+0

0.19

0.72

0.08

HLA-DRB1� 09:01

160

0.39 (0.17–0.91)

2.90E-2

1.00E+0

0.19

0.47

0.34

�

HLA-A� 01:01

521

1.40 (1.03–1.91)

3.29E-2

1.00E+0

0.97

0.02

0.00

HLA-C� 07:02

976

1.28 (1.02–1.62)

3.55E-2

1.00E+0

0.45

0.51

0.05

HLA-B� 14:01

56

2.16 (1.03–4.55)

4.26E-2

1.00E+0

0.95

0.00

0.05

HLA-B� 81:01

47

2.38 (1.02–5.54)

4.44E-2

1.00E+0

0.09

0.09

0.83

460

1.36 (1.00–1.85)

4.86E-2

1.00E+0

0.90

0.05

0.06

�

HLA-B 07:02

HLA alleles that were nominally associated with MS (p < 0.05) and their ancestry proportions estimated from RFMix. Odds ratio (OR) of association for case-control
comparison are also shown along with their 95% confidence interval. All tested HLA alleles passed imputation quality score (R2 > 0.80) and had allele frequencies
greater than 0.005. N = number of alleles; EUR = European; AMR = American; AFR = African. Adj P value = Bonferroni adjusted p-value.
https://doi.org/10.1371/journal.pgen.1007808.t006
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Table 7. Ancestry of HLA alleles associated with MS in Asian Americans.
Allele

N

OR

P value

Adj P value

EUR

EAS

HLA-B� 27:05

50

6.74 (1.92–23.66)

2.92E-3

1.34E-1

0.98

0.02

HLA-DRB1� 15:01

1228

1.88 (1.19–2.99)

7.26E-3

3.34E-1

0.07

0.93

HLA-C� 03:04

1687

1.69 (1.04–2.76)

3.43E-2

1.00E+0

0.04

0.96

HLA-DRB1� 12:02

1139

0.32 (0.11–0.94)

3.75E-2

1.00E+0

0.00

1.00

HLA alleles that were nominally associated with MS (p < 0.05) and their ancestry proportions estimated from RFMix. Odds ratio (OR) of association for case-control
comparison are also shown along with their 95% confidence interval. All tested HLA alleles passed imputation quality score (R2 > 0.80) and had allele frequencies
greater than 0.005. N = number of alleles; EUR = European; EAS = East Asian. Adj P value = Bonferroni adjusted p-value.
https://doi.org/10.1371/journal.pgen.1007808.t007

(n = 534 alleles)[14]. However, it is striking that HLA-DRB1� 15:01 is 92.9% East Asian in
Asian Americans (n = 1,228 alleles).
We searched for MS-associated HLA alleles that are potentially ancestry-specific, imposing
a 96% ancestry cutoff because we were able to correctly estimate the ancestry of HLA alleles of
known ancestry as 96% or greater. Briefly, we considered an MS-associated allele as a candidate ancestry-specific allele if at least 96% of its ancestry comes from a single ancestry across
all admixed populations in which it exists, and/or is missing in the rest of admixed populations. An allele could be missing because it does not exist in other ancestries (e.g. African
HLA-DRB1� 15:03), or because it did not pass quality control for imputation. Using this
approach, we classified HLA-DRB1� 14:02 and HLA-DRB1� 16:02 as Native American alleles,
HLA-DRB1� 15:03 as an African risk allele, HLA-DRB1� 12:02 as an East Asian allele, and HLAB� 55:01, HLA-B� 27:05, and HLA-A� 01:01 as European alleles.

Risk of MS between European and African HLA alleles in African
Americans
Given that African Americans exhibit two-way admixture and many MS-associated HLA
alleles in African Americans are relatively admixed, we studied the differential risk of HLA
alleles in African Americans based on ancestry. We first performed a case-control study of the
prominent MS risk allele HLA-DRB1� 15:01 in African Americans to determine whether there
were any differences in risk conferred by HLA-DRB1� 15:01 alleles of European and African
origin. We removed 12 alleles from the analysis, of which 6 were from cases and 6 were from
controls, whose HLA-DRB1� 15:01 allele was not inferred to be completely European or African. Table 8 shows the final number of alleles by ancestry and by case status. The risk of MS
conferred by the European HLA-DRB1� 15:01 allele was determined from logistic regression to
be three times higher compared to the African HLA-DRB1� 15:01 allele (OR = 3.00, 95% CI:
1.90–4.76, p = 2.49 × 10−6), after adjusting for the first 3 MDS components. We restricted the
logistic regression to alleles from individuals with one copy of HLA-DRB1� 15:01 so that the
association was not confounded by number of HLA-DRB1� 15:01 alleles.
We continued the same analyses for other alleles in Table 5. Alleles with a sample size less
than 50 or with a predominant ancestry of more than 90% are excluded from the analysis.
This analysis further revealed that European HLA-B� 07:02 (OR = 1.66, 95% CI: 1.12–2.47,
p = 1.18 × 10−2) and HLA-A� 03:01 (OR = 1.54, 95% CI: 1.04–2.29, p = 2.97 × 10−2) conferred
a greater risk of MS compared to their African counterparts at p < 0.05. However, for the
risk allele HLA-DRB1� 03:01, the European allele is protective (OR = 0.64, 95% CI: 0.43–0.96,
p = 3.03 × 10−2) compared to the African allele. Hence, this provides additional evidence that
the European haplotype confers more risk of MS compared to the African haplotype for other
HLA alleles, although this is not true for every allele (S1 Table).
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Fig 5. Admixture of HLA alleles associated with MS. Ancestry was inferred for MS-associated HLA alleles that passed QC using
RFMix. MS-associated alleles were significant at the nominal level (p < 0.05), had imputation score R2 > 0.80, and had minor allele
frequency greater than 0.005. Other than HLA-B� 55:01 in (A) African Americans, HLA-DRB1� 15:01, HLA-DRB1� 16:02,
HLA-DRB1� 01:01, HLA-DRB1� 14:02, HLA-A� 01:01 in (B) Hispanics, and HLA-B� 27:05 and HLA-C� 03:04 in (C) Asian Americans,
HLA alleles associated with MS are cosmopolitan.
https://doi.org/10.1371/journal.pgen.1007808.g005

SNP2HLA imputes SNPs and amino acids (AA) for the exons of HLA alleles, with a 1-to-1
mapping between a SNP and AA subsequence (see Methods). Given that European HLADRB1� 15:01 conferred three times the odds of MS compared to African HLA-DRB1� 15:01,
and without evidence that this finding was due to HLA-DQB1� 06:02 (S2 and S3 Tables), we
compared the most representative SNP and AA subsequences for European and African
HLA-DRB1� 15:01 alleles to look for differences. A large majority (94.1%) of European
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Table 8. HLA-DRB1� 15:01 of European origin confers greater risk of MS compared to DRB1� 15:01 of African
origin.
HLA-DRB1� 15:01 Ancestry

Case (n)

Control (n)

European

129

191

319

African

43

137

180

171

328

499

Two-by-two table of counts of HLA-DRB1� 15:01 alleles by ancestry and case/control status. The HLA-DRB1� 15:01
allele passed imputation quality score (R2 > 0.80) and had allele frequency greater than 0.005. Alleles that are not
completely European or African were removed.
https://doi.org/10.1371/journal.pgen.1007808.t008

HLA-DRB1� 15:01 alleles shared the same SNP and AA subsequences, whereas African
HLA-DRB1� 15:01 subsequences were more diverse. Data in S4–S7 Tables summarize the numbers of SNP and AA subsequences and S8 and S9 Tables show the genetic coordinates and
AA positions for the imputation of HLA-DRB1 subsequences. Fig 6 shows the comparison of
the most frequent (94.1%) SNP and AA subsequence for European HLA-DRB1� 15:01 alleles
against the top two most frequent (59.4% and 27.8% respectively) subsequences for African
HLA-DRB1� 15:01 alleles, respectively. All differences between the European subsequence and
the most frequent African subsequence were within exon 1. When compared against the second most frequent African subsequence, differences were found in exons 1, 3, and 6.

Ancestry association at non-HLA MS genetic risk loci
We evaluated the association of European ancestry with MS for 200 established non-HLA
genetic risk loci identified in White, non-Hispanic individuals. Following quality control
(QC), 165 MS risk variants were available in African Americans, 167 MS risk variants
in Hispanics, and 154 MS risk variants in Asian Americans for analysis. We tested each
risk variant for association with MS and tested each genetic locus for association between
European ancestry and MS. Data in S10–S12 Tables summarize the results for each admixed
population, respectively. Increased East Asian ancestry in MS cases compared to controls
for SNPs rs405343 (p = 5.53 × 10−13) and rs6670198 (p = 6.13 × 10−8) was observed in
Asian Americans. No other genetic risk locus showed evidence of increased ancestry in cases
compared to controls in any admixed population after adjustment for multiple tests. The risk
allele T for SNP rs405343 was significantly associated with MS (OR = 2.55, 95% CI: 1.70–3.83,

Fig 6. European and African HLA-DRB1� 15:01 subsequence comparison. Comparison of SNP and AA subsequences imputed by
SNP2HLA for European and African HLA-DRB1� 15:01 alleles in African Americans. Note: subsequence implies the SNPs and AAs
are not necessarily contiguous. The subsequences were aligned by position (GRCh38) with the UCSC genome browser NCBI gene
track; the imputed positions correspond to exons 1–5 of HLA-DRB1. The top frequent (94.1%) SNP and amino acid subsequence for
European HLA-DRB1� 15:01 was compared against the top two frequent (59.4% and 27.8%) subsequences for African
HLA-DRB1� 15:01. Red indicates a mismatch between any two given positions between an African and European allele. AA = amino
acid; EUR = European; AFR = African.
https://doi.org/10.1371/journal.pgen.1007808.g006
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p = 6.87 x 10−6) in Asian Americans; however, the risk allele T for SNP rs6670198 showed no
evidence for association. A small proportion of MS risk alleles overall demonstrated a nominal
level of association at p < 0.05: 13 SNPs in African Americans, 21 SNPs in Hispanics, and 28
SNPs in Asian Americans. With our sample sizes, the powers of detection for African Americans, Hispanics, and Asians are estimated to be 21.5%, 26.5%, and 11.7%, respectively. Assuming the established MS non-HLA alleles are also associated with MS in admixed populations,
then 35, 44, and 18 non-HLA alleles are expected to be detected in African Americans, Hispanics, and Asian Americans respectively, post quality control.
We determined whether European ancestry, both globally and locally at the non-HLA
genetic risk loci, was correlated with a cumulative genetic risk score in African American,
Asian American, and Hispanic MS cases. S1 Fig (S25 Table) shows results for each admixed
population. Globally, no evidence for significant correlation was observed in African Americans (R = 0.04, p = 0.47), Hispanics (R = 0.06, p = 0.30), or Asian Americans (R = 0.25,
p = 0.05); similar results were observed for local ancestry in all populations. Admixture estimates showed that the majority of the non-HLA variants investigated here were cosmopolitan;
local admixture was reflective of global admixture patterns (Fig 7, S24 Table).

Whole-genome association scan
We searched across the genome in African Americans, Asian Americans, and Hispanics to
identify regions where individuals with MS had a higher proportion of European ancestry

Fig 7. Admixture of non-HLA MS risk variants. Local ancestry estimates from RFMix for the non-HLA risk variants that passed
QC, sorted in order of increasing European ancestry. The admixture proportions of risk variants were estimated separately in (A)
African American cases, (B) African American controls, (C) Hispanic cases, (D) Hispanic controls, (E) Asian American cases, and
(F) Asian American controls. The ancestry proportions of risk variants in cases and controls were largely reflective of global
admixture proportions in cases and controls, respectively.
https://doi.org/10.1371/journal.pgen.1007808.g007
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compared to controls using the test statistic in Eq 1. The Q-Q plots in S2A and S2B Fig show
that the admixture mapping test statistics are approximately normally distributed except at the
tails. The test statistics are least normally distributed for Asian Americans, which exhibits the
most imbalance between cases and controls. The strongest peak of association observed was
identified in a single region at chromosome 8 from 207,207–314,620 (GRCh37) in Hispanics
that corresponds to an increase in European ancestry in cases compared to controls (S13–S15
Tables and Fig 8). This is the only peak that reached genome-wide significance with a Bonferroni adjusted p-value of 3.36 × 10−2. The closest gene to this region is ZNF596, a zinc finger
protein 9.8 kb downstream that is most highly expressed in the brain and cerebellum out of 20
different human tissues whose total RNA was sequenced[14].

Discussion
The genetic contribution to MS susceptibility is very complex; most studies have focused
on populations of Northern European descent, and to date, the involvement of genes within
and outside the MHC region has been established. Admixed individuals are derived from distinct ancestral populations; global and local genetic ancestry estimates can be used to test for
association between the genome, a genetic locus or specific allele and a phenotype of interest
[12,15,16]. This is one of the first studies to examine the relationship between genetic ancestry,
HLA and non-HLA alleles and MS in three admixed populations: African Americans, Hispanics, and Asian Americans.
Within the MHC, we were first able to replicate the association of some previously established HLA risk alleles with MS[11]; HLA-DRB1� 15:01 was the most significant finding across
all three admixed populations[5]. Here, the odds ratios (ORs) for HLA-DRB1� 15:01 observed
in admixed populations (1.88–2.45) were slightly lower than described in previous reports for
White, non-Hispanic individuals (2.92)[11], but the direction of effect is consistent. In African
Americans, we further replicated the association and direction of effect of HLA alleles previously established in the White, non-Hispanic population: HLA-DRB1� 03:01, HLA-A� 02:01,
HLA-DRB1� 14:01, and HLA-B� 38:01 at nominal level significance (p < 0.05)[11]. Additionally, we replicated the African HLA risk allele HLA-DRB1� 15:03 in African Americans[9]. A
similar study by Isobe, et al. also replicated the association of HLA alleles HLA-DRB1� 15:01,
HLA-DRB1� 03:01, HLA-DRB1� 15:03, and HLA� 02:01. Although HLA-DRB1� 14:01 was not
found by Isobe to be significantly associated (P-value = 0.070), its protective effect is consistent
with what is observed in this study. In summary, we detected association for 5 of the 6 established HLA MS alleles expected to be replicated under power calculations, and this supports
the hypothesis that the MS genetic risk in African Americans partially overlaps with that of
Europeans[17]. In both Hispanics and Asian Americans, HLA-DRB1� 15:01 is the only established HLA risk allele in White, non-Hispanics that was replicated[11], which suggests a
smaller overlap in MS genetic risk between Hispanics and Asian Americans with that of
Europeans.
At a nominal level of significance (p < 0.05), analysis of the HLA alleles identified five
candidate risk alleles and four candidate protective alleles for African Americans, nine candidate risk alleles and four candidate protective alleles for Hispanics, and two candidate risk
alleles and one candidate protective allele for Asian Americans. All directions of effect (risk
or protective) of candidate MS HLA alleles are the same if found in more than one admixed
population. In total, four of the nine protective HLA alleles novel in this study for MS belong
to class I genes and five are class II DRB1 alleles. It is plausible that the lower prevalence of
MS in some admixed populations could be partially explained by the effects of protective
alleles.
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Fig 8. Genome-wide association of European ancestry with MS. P values from testing of association between
European ancestry and MS using non-parametric test statistic proposed by Montana and Pritchard, as described in
Methods. One locus was selected from each 0.2 cM window used by RFMix for ancestry inference to reduce the
burden of multiple hypothesis testing, resulting in 15,282 tests. The red horizontal line indicates the negative log of the
Bonferroni P value (p = 3.27 × 10−6) for establishing significance. (A) None of the loci tested for African Americans
demonstrated evidence for significant association. (B) In Hispanics, a region spanning from 2Mb to 3Mb on
chromosome 8 showed evidence for a significant association. (C) None of the loci tested for Asian Americans were
significantly associated.
https://doi.org/10.1371/journal.pgen.1007808.g008
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Of the significantly associated HLA haplotypes and alleles reported by Mack, et al. in Europeans, three were nominally associated with MS in at least one admixed population in this
study[18]. In particular, the HLA-DRB1� 03:01 and HLA-A� 02:01 alleles in African Americans
exhibited similar ORs and direction of effect (Table 5). However, the HLA-C� 03:04 allele in
Asian Americans conferred risk (OR = 1.69) instead of a protective effect (Table 7). It is plausible that this disagreement is because an overwhelming majority (95.7%) of HLA-C� 0304 alleles
in Asian Americans are of East Asian origin in this study, while the investigation by Mack,
et al. was in European Americans (Fig 5C, S23 Table and Table 7). The exon differences
observed between European and African HLA-DRB1� 15:01 suggests that future high-resolution HLA analysis could further explain the differences in risk and protective effects that is due
to ancestry.
The entire MHC region spanning 29,570,005–33,377,701 (GRCh37) had a higher proportion of European ancestry in MS cases compared to controls for both African American and
Hispanic populations. In Asian Americans, the MHC region had a higher proportion of East
Asian ancestry in cases compared to controls. Interestingly, the local MHC ancestry associations observed in the current study for African Americans and Hispanics contrasted with
global ancestry—African American and Hispanic cases demonstrated less European ancestry
compared to controls when the whole genome was taken into consideration, and Asian American cases demonstrated more European ancestry compared to controls. To investigate these
associations further, we characterized the admixture proportions of MS-associated HLA
alleles. Fig 5 (S23 Table) shows that a majority of HLA alleles, including HLA-DRB1� 15:01,
were inferred to exist in multiple ancestries and could thus be considered cosmopolitan. African American cases were not significantly European at the class II region compared to controls
likely due to the contribution of the common African allele HLA-DRB1� 15:03. In Asian Americans, HLA-DRB1� 15:01 and HLA-C� 03:01 conferred risk of MS and accounted for 68.6% of
HLA alleles associated with MS. Together, these two alleles had an average of 94.7% East Asian
ancestry which helps explain why cases tended to have a higher proportion of East Asian
ancestry compared to controls within the MHC region.
We find it noteworthy that the European HLA-DRB1� 15:01 allele confers three times the
odds of MS compared to the African HLA-DRB1� 15:01 allele in the African Americans we
studied. A similar effect has been observed for European HLA-B� 07:02 and HLA-A� 03:01.
Together these findings provide evidence that in some genetic regions, the European haplotype
could confer more risk of MS than haplotypes derived from other ancestries. In these cases, it
is plausible that disease-causing genetic variants can come from only one ancestral population.
However, it must be noted that this has not been found to be true for all admixed MS-associated alleles we examined (S1 Table), and that for alleles such as the African MS risk allele
HLA-DRB1� 15:03, the African haplotype confers more risk than the European haplotype.
These findings together further highlight the complex genetic ancestry of MS-associated alleles
in admixed populations.
Given that HLA-DRB1� 15:01 is in very strong linkage disequilibrium with HLADQB1� 06:02 in Europeans, we investigated whether the increased risk of MS in African Americans conferred by European HLA-DRB1� 15:01 could possibly be due to HLA-DQB1� 06:02,
despite the limitation that HLA-DQB1 did not pass our imputation quality cutoff (average
R2 = 0.53 across all DQB1 alleles). As expected, 99.5% of HLA-DRB1� 15:01 haplotypes that
include HLA-DQB1� 06:02 in African Americans are of European ancestry. Counts of all
observed DRB1� 15:01-DQB1 haplotypes are shown in S16 and S17 Tables. S1 Table shows
that HLA-DQB1� 06:02 was not associated with MS in African Americans (OR = 1.14, 95% CI:
0.68–1.92, p = 0.72). Further, S3 Table shows that comparison of European HLA-DQB1� 06:02
alleles with African HLA-DQB1� 06:02 alleles, in the absence of HLA-DRB1� 15:01, did not
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demonstrate evidence for a significant association (OR = 0.48, 95% CI: 0.23–1.00, p = 0.07);
the direction of effect is, in fact, protective. Results from the current study are consistent with a
previous report showing the association of MS with the HLA-DRB1� 15:01-DQB1� 06:02 haplotype is due to the DRB1 locus independent of DQB1� 06:02[19].
A comparison of the most commonly imputed SNP and AA subsequences between European and African HLA-DRB1� 15:01 alleles revealed mismatches at exons 1, 3, and 5. Each of
these exons help encode the DR beta 1 heterodimer, with exon 1 encoding the leader peptide
and exon 5 encoding the cytoplasmic tail of the membrane protein. Exon 3, together with exon
2, encode the two extracellular domains[20]. Further investigation into whether genetic variation in these exons have functional consequences for peptide presentation in the context of MS
is warranted. Our case study of HLA-DRB1� 15:01 illustrates how admixture mapping can be
broadly applied to better characterize risk alleles in admixed populations.
Consistent with previous attempts to replicate the association of non-HLA genetic risk variants, we also failed to replicate association of most non-HLA genetic risk variants across all
three admixed populations, except for rs405343 and rs6670198 in Asian Americans, which
exhibit the same direction of effect as in whites[8,9,21]. Without correction for multiple testing
with significance established at p < 0.05, we replicated the association of 13 SNPs in African
Americans, 21 SNPs in Hispanics, and 28 SNPs in Asian Americans (S10–S12 Tables). For
African Americans and Hispanics, we replicated less associations than is expected under
power calculations. For Asian Americans, more associations were replicated than is expected.
The majority of non-HLA MS risk variants identified so far appears to be cosmopolitan and
their observed ancestry proportions are reflective of global admixture proportions (Fig 7, S24
Table). European global ancestry and European local ancestry at the non-HLA genetic risk loci
was not correlated with the unweighted genetic risk score comprised of the non-HLA variants
(S1 Fig, S25 Table). Although our investigation showed that the majority of non-HLA MS
genetic risk variants reported for the White, non-Hispanic population do not demonstrate
strong associations with MS in African Americans, Asian Americans, and Hispanics, our
study is under-powered to detect most associations. Besides lacking power due to small sample
and effect sizes, there are multiple other explanations for why we may fail to replicate many
associations of the non-HLA genetic risk variants with MS[9]. One explanation is that differences in minor allele frequencies reduced the power to detect associations in admixed populations. Another explanation is that the smaller haplotype blocks of African Americans and
Hispanics may have caused many non-HLA genetic risk variants to fail tagging the putative
causative variant of MS. Lastly, the absence of replication could simply be due to genetic heterogeneity across populations, which further justifies the need for GWAS in non-White
populations.
A genome-wide search for European ancestry differences between MS cases and controls
in all three admixed populations resulted in one region of chromosome 8 from 207,207 to
314,620 (GRCh37) in Hispanics only. The closest gene to this region is ZNF596, a zinc finger
protein 9.8 kb away that is highly expressed in the brain and cerebellum. Lesions in brain tissue
as well as brain atrophy are pathological hallmarks of MS[22], and available data suggest Hispanics may have a more severe disease course than White, non-Hispanic individuals[23]; however, these findings await replication. Further investigation of this region in a larger
independent dataset and full interrogation of nearby genes and determining whether ZNF596
could be involved in MS pathogenesis from a functional perspective are warranted.
Some important strengths of this study included comprehensive analyses of a large, wellcharacterized dataset comprised of 12,384 admixed MS cases and controls with high quality
genetic data, the application of rigorous quality control procedures, genetic imputation
methods for both SNP and HLA loci, probabilistic graphical modeling for local admixture
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estimation across the genome, and non-parametric statistical testing to identify local admixture differences between cases and controls that accounts for global differences. In the current
study, the combined analysis of SNP and HLA genotypes in African Americans revealed for
the first time, strong evidence that the European HLA-DRB1� 15:01 allele confers three times
the MS risk compared to the African HLA-DRB1� 15:01 allele. This finding indicates increased
risk attributed to the European 15:01 allele could be due to functional differences within DRB1
itself, or possibly due to variant(s) present on the European HLA-DRB1� 15:01 haplotype that
are not found on the African haplotype.
Some limitations must also be acknowledged. The diagnosis of MS cases in this large dataset
occurred over a twenty-five year period and in different clinical settings; both prevalent and
incident cases were included. Although all cases fulfilled established diagnostic criteria, is not
known whether local genetic ancestral proportions (of particular importance in the current
study) would be expected to change for cases diagnosed at different time points; larger investigations would be needed. We performed MDS analysis of genotype data to broadly categorize
samples as African Americans, Asian Americans, or Hispanics for case-control analysis; careful matching on self-reported race/ethnicity was not possible for all individuals. MDS components were therefore used in each analysis to control for potential confounding; however, it is
possible that population stratification could still contribute to some of our findings. The Asian
MS case sample utilized in the current study was small compared to the other groups, reflecting the low prevalence of disease in this population, which reduced power to detect to modest
effects.
In conclusion, results from the current study reveal a complex picture of genetic ancestry
for MS-associated alleles in African Americans, Asian Americans, and Hispanics. Our study
shows that the higher prevalence of MS in populations of northern European ancestry cannot
simply be explained by the European ancestral origin of genetic risk factors. Rather, any difference in prevalence due to genetics might be partially explained by a combination of European
risk alleles exerting greater risk (i.e. HLA-DRB1� 15:01) compared to non-European risk alleles,
or the presence of protective alleles in individuals of non-European ancestry. However, this
does not rule out the possibility that observed prevalence differences could result from the
influence of environmental risk factors or socioeconomic status, including differences in
access to neurologists and diagnostic protocols using MRI, that may be population-specific.

Materials and methods
Ethics statement
Institutional Review Board approval was obtained for this study by the UC Berkeley Committee on Protection of Human Subjects (CPHS) (2010-03-928); PROTOCOL TITLE: Genetic
and non genetic risk factors for MS; UC San Francisco Human Research Protection Program
Institutional Review Board (IRB) (10–05039); PROTOCOL TITLE: Environmental and
genetic risk factors for pediatric multiple sclerosis; Kaiser Permanente Southern California
IRB (5962); PROTOCOL TITLE: MS Sunshine Study; and Kaiser Permanente Northern California IRB (CN-03CScha-05-H); PROTOCOL TITLE: Genetic and Non-Genetic Predictors of
Risk for Multiple Sclerosis. Written informed consent was obtained for all study participants
at these sites.

Sample collection and genotyping
Genotype data from a total of 21,647 subjects were collected from the Northern and Southern
California Kaiser Permanente memberships, the U.S. Pediatric MS Network, the Genetic Epidemiology Research on Aging (GERA) cohort, and International Multiple Sclerosis Genetics
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Table 9. Dataset sources for admixed populations.
Source

Case (n)

Control (n)

Northern California Kaiser Permanente

1,069

637

Southern California Kaiser Permanente

645

636

U.S. Pediatric MS Network

792

413

IMSGC ImmunoChip

803

462

0

16,168

3,320

18,327

Genetic Epidemiology Research on Aging
Total

Starting number of cases and controls for each dataset source. n = number of individuals.
https://doi.org/10.1371/journal.pgen.1007808.t009

Consortium (IMSGC). Table 9 shows the starting number of MS cases and controls by dataset.
All cases met the diagnostic criteria for MS[24,25]. Subjects from Northern California Kaiser
Permanente and U.S. Pediatric MS Network were genotyped on the Illumina Human660WQuad BeadChip, Infinium Human OmniExpress BeadChip, and Infinium Human OmniExpress Exome BeadChip. Subjects from Southern California Kaiser Permanente were genotyped
on OmniExpress platforms. The 1,265 African American subjects from IMSGC were genotyped using the Illumina Immunochip and combined with other African Americans to study
the ancestry of the MHC region[8]. Note that IMSGC subjects were not genotyped genomewide and were thus excluded from the genome-wide studies in this paper.
Genotyping details for the GERA cohort are described elsewhere[26]. All genetic coordinates were converted to NCBI Build 37 before analysis. BEAGLE was used to obtain phased
data for African Americans, Asian Americans, and Hispanics independently, using GRCh37
genetic map positions in centimorgans converted from GRCh37 genetic coordinates by BEAGLE utility software. Genetic map positions capture genetic linkage information and is used
by RFMix for defining windows for local ancestry assignment. The reference panel used for
phasing was constructed from selecting individuals from 1000 Genomes with ancestries present in each admixed population[27,28]. The ancestries represented in our dataset were European (present in all groups), African (present in African Americans and Hispanics), East Asian
(present in Asian Americans), and Native American (present in Hispanics).

Imputation
Genome-wide imputation of the dataset against the entire 1000 Genomes phase 3 reference
panel was carried out using IMPUTE2[27,29]. For HLA imputation, SNP2HLA was used to
perform 2-field imputation of alleles for HLA-A, HLA-B, HLA-C, DRB1, and DQB1 using an
admixed reference panel from the 1000 Genomes Project, comprised of 165 Native Americans,
155 Africans, 251 East Asians, and 303 Europeans[27,30,31]. The reference panel was tailored
to contain ancestries represented by the target population to enhance imputation accuracy,
and HLA alleles in each admixed population were imputed independently as previously
described[32].

Quality control
SNPs were filtered for minor allele frequency (> 0.01) and missingness on SNPs and samples
(> 0.10) before and after imputation with IMPUTE2. Genotype probabilities from IMPUTE2
were converted to hard genotype calls using > 0.6 as the threshold, and SNPs were filtered for
info score > 0.30. Additionally, A/T and C/G SNPs were discarded prior to local ancestry
inference to avoid strand ambiguity. Related individuals (^
p >0:25) were removed from further
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analysis, resulting in a total of 20,588 samples. For HLA imputation using SNP2HLA, we
removed alleles with R2 scores less than 0.80 and with allele frequencies below 0.005 from further analysis, filtering out 40, 66, and 63 HLA alleles to result in 70, 47, and 77 HLA alleles for
African Americans, Asian Americans, and Hispanics, respectively. All quality control (QC)
steps were performed using the PLINK software and R v3.3.1 (www.r-project.org)[33].

Analysis of population structure
Population structure was assessed using MDS and fastSTRUCTURE prior to genotype imputation in order to divide the samples into African American, Asian American, or Hispanic
groups for further analysis[34]. MDS components captured ancestry to identify individuals
likely to be African American, Asian American, or Hispanic, using reference populations from
the Human Genome Diversity Project (HGDP)[35]. Subjects that cluster with the European
reference samples were identified as White, non-Hispanic and subsequently removed. Then,
fastSTRUCTURE was used for each group to estimate global admixture proportions for individuals using independent SNPs and a HGDP reference panel tailored to the target population,
with default parameters. A cutoff of at least 5% Native American global ancestry for Hispanics
was imposed to further remove White, non-Hispanic individuals who were removed based on
MDS. The 1,163 candidate Hispanic individuals who did not meet this requirement had an
average 0.7% Native American ancestry and 96% European ancestry.

Local ancestry inference
We inferred local ancestry genome-wide separately for African Americans, Asian Americans,
and Hispanics using RFMix software analysis of imputed and phased genotype data, and a reference panel from the 1000 Genomes Project tailored to the target population[27,36]. The
1000 Genomes reference panel was selected over the HDGP reference panel as the appropriate
reference because it has the required high genotype density for local ancestry inference. RFMix
was run on recommended input parameters of 5 minimum number of reference haplotypes
per tree node and 3 EM iterations. The number of generations of admixture used as input
parameters for RFMix were 5, 6, and 11 for Asian Americans, African Americans, and Hispanics, respectively, according to previous estimates for populations in the United States [37].

Statistical analysis
Association testing between case status and genetic ancestry was performed using the nonparametric test statistic proposed by Montana and Pritchard for admixture mapping[38].
Tðl; kÞ ¼

ð�z l; d ðkÞ

�z l; c ðkÞÞ
SDð�z l; d ðkÞ

ð�
q d ðkÞ q�c ðkÞÞ
�z l; c ðkÞÞ

ð1Þ

Briefly, the term �z l; d ðkÞ represents the average local ancestry of cases at locus l for ancestry
k and �z l; c ðkÞ is similarly defined for controls. The term q�d ðkÞ represents the genome-wide
average of ancestry k among cases and q�c ðkÞ is defined similarly for controls. Genome-wide
ancestry estimates for this statistic are taken from local ancestry estimates from RFMix. This
test statistic can be used to test for ancestry association at a single locus or at a region. Under
the null, the test statistic follows the normal distribution and a P value can be obtained through
a z-test. The variance Varð�z l; d ðkÞ �z l; c ðkÞÞ of the test statistic at a given locus was empirically
estimated as the sum of variance of average ancestry among cases and controls. The standard
deviation follows as the square root of the variance. This estimation corresponds to estimating
the standard deviation of the average treatment effect, with disease status as treatment and
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ancestry as outcome[39]. All terms of the test statistic were estimated from local ancestry estimates from RFMix. Complete details are described elsewhere[38].
Multivariate logistic regression was applied to evaluate the association of genetic variants
with MS, using an additive model and adjusting for the first three MDS components to control
for population stratification[8,9]. ORs were used to characterize effect sizes of MS risk alleles.
The Wilcoxon test was used to evaluate significance of global admixture proportion differences
between cases and controls. All analyses were performed using PLINK and R v3.3.1 (www.rproject.org)[33].
Multiple hypothesis testing was addressed with Bonferroni correction. Bonferroni correction was used to establish significance for the study of non-HLA alleles, and adjusted p-values
were provided for all multiple testing scenarios except when the number of tests is ten or less.
For genome-wide association studies, a significance level of α = 0.05 with 15,282 tests results
in a genome-wide significance level of 3.27 × 10−6. Bonferroni correction was applied independently for the studies of African Americans, Hispanics, and Asian Americans.
Since local ancestry assignments span multiple loci, we reduced the burden of multiple
hypothesis testing for ancestry association across the genome by only testing one locus per
window defined by RFMix for inferring local ancestry, resulting in a total of 15,282 tests
genome-wide. Complete details of how RFMix defines windows for local ancestry inference is
described elsewhere[36].

Power calculations
Power calculations are performed with the Genetic Association Study Power Calculator
(http://csg.sph.umich.edu/abecasis/cats/gas_power_calculator/), which implements calculations from Skol et al.[40]. We assume an additive disease model, a MS prevalence of 0.1% in
the United States, significance level of 5%, and disease allele frequency of 10%[41]. For HLA
alleles, we assume a relative risk of 2, and a relative risk of 1.2 for non-HLA alleles.

Comparison of SNP and amino acid subsequences
SNPs and AAs imputed by SNP2HLA for European and African HLA-DRB1� 15:01 alleles in
African Americans were aligned to the UCSC Genome Browser GRCh38 RefSeq Genes track,
and the European subsequences were compared to the African subsequences. Note that “subsequence” refers to only the imputed SNPs and AAs, and not to contiguous DNA or AA
sequence.

Supporting information
S1 Fig. Unweighted genetic risk score versus European ancestry. Plot of unweighted genetic
risk score of the MS genetic risk variants passing QC versus European ancestry globally and
locally at the corresponding MS genetic risk loci. All ancestries were estimated with RFMix.
Panels (A), (C), and (E) shows the relationship between risk score and percentage European
global ancestry for African Americans, Hispanics, and Asian Americans respectively. Panels
(B), (D), and (F) shows the relationship between risk score and percentage European local
ancestry calculated at the MS genetic risk loci for African Americans, Hispanics, and Asian
Americans. There was little correlation (R2 < 0.30; P-value > 0.05) between genetic risk score
and European ancestry.
(TIFF)
S2 Fig. Q-Q plot of admixture mapping test statistic. Q-Q plot of admixture mapping test
statistic for (A) African Americans, (B) Hispanics, and (C) Asian Americans. The line y = x
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represents the theoretical Q-Q plot if the test statistics are perfectly normally distributed.
(TIFF)
S1 Table. Odds ratio of MS for European allele versus African allele. Odds ratio (OR) of
European HLA allele to African HLA allele as determined from logistic regression for African
American MS-associated alleles, adjusting for first 3 MDS components. OR are shown with
95% confidence interval and corresponding p-values. HLA alleles with sample size less than 50
or with predominant ancestry greater than 90% are excluded from the analysis. Furthermore,
alleles not inferred to be completely European or African are excluded, and only alleles from
individuals with one copy are included.
(PDF)
S2 Table. HLA-DRB1� 15:01 haplotypes in African Americans. Two-by-two table of counts
of DRB1� 15:01–DQB1 haplotypes where DRB1� 15:01 is European and the identity of the
DQB1 allele on the haplotype is summarized. All HLA alleles had allele frequency greater than
0.005, and only DRB1� 15:01 alleles that were completely European were considered. DQB1� X
denotes any DQB1 allele that is not DQB1� 06:02, and that there is no restriction on the ancestry of the DQB1 allele. Note: DQB1 alleles did not pass imputation quality cutoff of r2 = 0.80
(see text for details).
(PDF)
S3 Table. European and African HLA-DQB1� 06:02 haplotypes in African Americans. Twoby-two table of counts of DRB1� X–DQB1� 06:02 haplotypes where DRB1� X denotes any allele
other than DRB1� 15:01. All HLA alleles had allele frequency greater than 0.005, and only
DQB1 alleles that were either completely European or African are considered. There is no
restriction on the ancestry of the DRB1 allele. Note: DQB1 alleles did not pass imputation quality cutoff of r2 = 0.80 (see text for details).
(PDF)
S4 Table. Imputed European HLA-DRB1� 15:01 SNP subsequences in African Americans.
Imputed SNPs for all European HLA-DRB1� 15:01 alleles in African Americans. SNPs are listed
left to right in order of increasing genetic coordinates. Note that imputed SNPs are not contiguous and imputation was performed by SNP2HLA.
(PDF)
S5 Table. Imputed African HLA-DRB1� 15:01 SNP subsequences in African Americans.
Imputed SNPs for all African HLA-DRB1� 15:01 alleles in African Americans. SNPs are listed
left to right in order of increasing genetic coordinates. Note that imputed SNPs are not contiguous and imputation was performed by SNP2HLA.
(PDF)
S6 Table. Imputed European HLA-DRB1� 15:01 amino acid subsequences in African Americans. Imputed amino acids (AA) for all European HLA-DRB1� 15:01 alleles in African Americans. AAs are listed left to right in order of increasing genetic coordinates. Note that imputed
AAs are not contiguous and imputation was performed by SNP2HLA.
(PDF)
S7 Table. Imputed African HLA-DRB1� 15:01 amino acid subsequences in African Americans. Imputed amino acids (AA) for all African HLA-DRB1� 15:01 alleles in African Americans. AAs are listed left to right in order of increasing genetic coordinates. Note that imputed
AAs are not contiguous and imputation was performed by SNP2HLA.
(PDF)
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S8 Table. Genetic coordinates of imputed HLA-DRB1� 15:01 SNPs. Genetic coordinates in
GRCh37 of SNPs imputed by SNP2HLA for HLA-DRB1� 15:01.
(XLSX)
S9 Table. Coordinates of imputed HLA-DRB1� 15:01 amino acids. Genetic coordinates in
GRCh37 and amino acid positions of amino acids (AA) imputed by SNP2HLA for HLADRB1� 15:01. Note that in SNP2HLA, amino acid position 1 starts from exon 2.
(XLSX)
S10 Table. Association signals of non-HLA MS risk variants in African Americans. Association testing of the established MS genetic risk variants with MS in African Americans. Association is evaluated for local European ancestry at risk loci and separately for MS risk variants.
Only risk variants that pass QC are tested. Abbreviations: OR = odds ratio; p value (RV) = p
value from testing of association between MS risk variant and MS; adj p value (RV) = Bonferroni-adjusted p value (RV); z score = admixture mapping test statistic; p value (EUR) = p value
from testing of association between European ancestry and MS; adj p value (EUR) = Bonferroni-adjusted p value (EUR). Positions are in NCBI build-37 coordinates.
(XLSX)
S11 Table. Association signals of non-HLA MS risk variants in Hispanics. Association testing of the established MS genetic risk variants with MS in Hispanics. Association is evaluated
for local European ancestry at risk loci and separately for MS risk variants. Only risk variants
that pass QC are tested. Abbreviations: OR = odds ratio; p value (RV) = p value from testing of
association between MS risk variant and MS; adj p value (RV) = Bonferroni-adjusted p value
(RV); z score = admixture mapping test statistic; p value (EUR) = p value from testing of association between European ancestry and MS; adj p value (EUR) = Bonferroni-adjusted p value
(EUR). Positions are in NCBI build-37 coordinates.
(XLSX)
S12 Table. Association signals of non-HLA MS risk variants in Asian Americans. Association testing of the established MS genetic risk variants with MS in Asian Americans.
Association is evaluated for local European ancestry at risk loci and separately for MS
risk variants. Only risk variants that pass QC are tested. Abbreviations: OR = odds ratio;
p value (RV) = p value from testing of association between MS risk variant and MS; adj
p value (RV) = Bonferroni-adjusted p value (RV); z score = admixture mapping test statistic;
p value (EUR) = p value from testing of association between European ancestry and MS; adj
p value (EUR) = Bonferroni-adjusted p value (EUR). Positions are in NCBI build-37 coordinates.
(XLSX)
S13 Table. Top association signals of genome-wide admixture mapping in African Americans. Top association signals from genome-wide scan of association between local European
ancestry and MS. The z score and p value from admixture mapping are shown. adj p value =
Bonferroni-adjusted p value. Positions are in NCBI build 37 coordinates.
(XLSX)
S14 Table. Top association signals of genome-wide admixture mapping in Hispanics. Top
association signals from genome-wide scan of association between local European ancestry
and MS. The z score and p value from admixture mapping are shown. adj p value = Bonferroni-adjusted p value. Positions are in NCBI build 37 coordinates.
(XLSX)
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S15 Table. Top association signals of genome-wide admixture mapping in Asian Americans. Top association signals from genome-wide scan of association between local European
ancestry and MS. The z score and p value from admixture mapping are shown. adj p value =
Bonferroni-adjusted p value. Positions are in NCBI build 37 coordinates.
(XLSX)
S16 Table. European DRB1� 15:01– DQB1� X haplotypes in African Americans. HLA-DQB1
alleles that European HLA-DRB1� 15:01 is linked to in African Americans. All HLA alleles
have frequency equal to or greater than 0.005, and there is no constraint on the ancestry of
HLA-DQB1 alleles. X = wildcard for any HLA-DQB1 allele.
(PDF)
S17 Table. African DRB1� 15:01– DQB1 haplotypes in African Americans. HLA-DQB1
alleles that African HLA-DRB1� 15:01 is linked to in African Americans. All HLA alleles
have frequency equal to or greater than 0.005, and there is no constraint on the ancestry of
HLA-DQB1 alleles. X = wildcard for any HLA-DQB1 allele.
(PDF)
S18 Table. MS genome-wide genetic variant associations outside the major histocompatibility complex region.
(PDF)
S19 Table. MDS components of study subjects and HGDP reference samples. Supporting
information for Fig 1.
(XLSX)
S20 Table. Average global ancestry proportions by admixed population. Supporting information for Fig 2.
(XLSX)
S21 Table. Change in European ancestry vs genome average in MHC region by admixed
population. Supporting information for Fig 3.
(XLSX)
S22 Table. P-values of MS-associated HLA alleles by admixed population. Supporting information for Fig 4.
(XLSX)
S23 Table. Ancestry proportions of HLA alleles associated with MS by admixed population. Supporting information for Fig 5.
(XLSX)
S24 Table. Ancestry proportions of non-HLA MS risk variants by admixed population.
Supporting information for Fig 7.
(XLSX)
S25 Table. MS risk score and European ancestry by admixed population. Supporting information for S1 Fig.
(XLSX)
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